1. Short title This Act may be cited as the Medical Product Communications Act of 2017 . 2. Communications regarding intended uses of drugs and devices; scientific exchange The Federal Food, Drug, and Cosmetic Act is amended by inserting after section 201 of such Act ( 21 U.S.C. 321 ) the following: 201A. Intended uses of drugs and devices (a) Intended use For purposes of this Act, including sections 301(d), 502(f)(1), 505, 510, and 515 and for purposes of section 351 of the Public Health Service Act, the intended use of a drug, biological product, or device— (1) shall be determined by reference to the objective intent of the manufacturer and sponsor of such drug, biological product, or device, or persons acting on the manufacturer’s or sponsor’s behalf, as demonstrated by statements contained in labeling, advertising, or analogous oral statements; and (2) shall not be determined by reference to— (A) actual or constructive knowledge of the manufacturer or sponsor that such drug, biological product, or device will be used in a manner that varies from the use approved for marketing under section 505, 510, or 515 of this Act or section 351 of the Public Health Service Act